Entera Bio Ltd reported raising $275 Million in an initial SEC Form D filing, from an offering of $275 Million
Amount Raised
$275 Million
Round Type
Post-IPO Equity
IsraelBiotechnologyHealthcareInvestors
Description
Entera Bio Ltd. has entered into a securities purchase agreement for an oversubscribed private placement financing expected to yield approximately $275 million. This funding is anticipated to support Phase 3 registrational studies for their oral PTH(1-34) peptide tablet. The offering is led by existing investor BVF Partners L.P., with participation from several new investors
Quick answer
Entera Bio Ltd raised $275 Million in a Post-IPO Equity round, dated July 27, 2026. Investors: Perceptive Advisors, Catalio Capital Management, Logos Capital, Driehaus Capital Management, Longitude Capital, Vivo Capital, Tcgx and Spruce Street Capital. Entera Bio Ltd is based in Israel.
- How much did Entera Bio Ltd raise?
- Entera Bio Ltd raised $275 Million in a Post-IPO Equity round on July 27, 2026.
- Who invested in Entera Bio Ltd?
- Perceptive Advisors, Catalio Capital Management, Logos Capital, Driehaus Capital Management, Longitude Capital, Vivo Capital, Tcgx and Spruce Street Capital are named as investors in this round.
- What does Entera Bio Ltd do?
- Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics.
- Where is Entera Bio Ltd based and how big is it?
- Entera Bio Ltd is based in Israel. Fundz records about 22 employees.
- Who are the decision-makers at Entera Bio Ltd?
- Fundz holds 2 contacts at Entera Bio Ltd, including the CFO. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Entera Bio Ltd that raised within 45 days of this round, from Fundz verified event records.
- Lexaria Bioscience raised $113K on September 9, 2026.
- Korsana Biosciences raised $380M (Post-IPO Equity) on September 8, 2026.
- CytoDyn raised $17M on September 1, 2026.
- Corvex Legacy Holdings raised $33M on August 31, 2026.
- Tenon Medical raised $4.3M (Series A) on August 31, 2026.
- Endovia Health Sciences, Inc. raised $108K (Funding Round) on August 28, 2026.
Who to call at Entera Bio Ltd, and when
A new round usually means Entera Bio Ltd is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Entera Bio Ltd raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Entera Bio Ltd, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Entera Bio Ltd. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Entera Bio Ltd raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Entera Bio Ltd raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.